Breast Cancer Drugs Market by Drug Type (Hormone Therapy, Chemotherapy Drugs, Targeted Therapy Drugs, and Other Therapeutic Drugs): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global breast cancer drugs market expected to generate around USD 38.3 billion by 2025, at a CAGR of around 10.55% between 2019 and 2025. The increasing breast cancer prevalence worldwide is the major driving factor for the global breast cancer drugs market along with increasing health awareness, healthcare spending, and rising disposable income of people.

15-Mar-2019 | Number of pages: 110 | Report Code: ZMR-70 | Report Format : | Status : Published

Abstract

The report covers a forecast and an analysis for the breast cancer drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the breast cancer drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the breast cancer drugs market on a global and regional level.

In order to give the users of this report a comprehensive view of the breast cancer drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Breast Cancer Drugs Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the breast cancer drugs market by segmenting the market based on drug type and region. Based on drug type, the market is segmented into chemotherapy drugs, hormone therapy drugs, targeted therapy drugs, and other therapeutic drugs.

Chemotherapy drugs are sub-segmented into anthracyclines, taxanes, antimetabolites, alkylating agents, and epothilones. Anthracyclines segment is split into doxorubicin and epirubicin. Taxanes are split into paclitaxel and docetaxel. Antimetabolites segment is classified into fluorouracil, capecitabine, and gemcitabine. Hormone therapy drugs are classified into selective estrogen-receptor modulators (SERMs), aromatase inhibitors, and other hormonal therapies. Selective estrogen-receptor modulators segment is further split into tamoxifen, raloxifene, and toremifene. Aromatase inhibitors segment is split into letrozole, anastrozole, and megestrol. Other hormonal therapy drugs include goserelin acetate, fulvestrant, fluoxymesterone etc. The targeted therapy drugs are classified into monoclonal antibodies (mAbs) and tyrosine kinase inhibitors. Monoclonal antibodies (mAbs) are further split into bevacizumab, trastuzumab, and other mAbs.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global breast cancer drugs market include AbbVie, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., AstraZeneca, Celgene Corporation, Eli Lilly and Company, Merck & Co., Inc., Biocon, Genzyme Corporation, MacroGenics, Inc., Janssen Global Services LLC, Onyx Pharmaceuticals Inc., Celldex Therapeutics, and BioNumerik Pharmaceuticals, Inc.

This report segments the global breast cancer drugs market into:

Global Breast Cancer Drugs Market: By Drug Type

  • Chemotherapy Drugs
    • Anthracyclines
      • Doxorubicin
      • Epirubicin
    • Taxanes
      • Paclitaxel
      • Docetaxel
    • Antimetabolites
      • Fluorouracil
      • Capecitabine
      • Gemcitabine
    • Alkylating Agents 
    • Epothilones
  • Hormone Therapy Drugs
    • Selective Estrogen-Receptor Modulators (SERMs)
      • Tamoxifen
      • Raloxifene
      • Toremifene
    • Aromatase Inhibitors
      • Letrozole
      • Anastrozole
      • Megestrol
    • Other Hormonal Therapies
      • Goserelin acetate
      • Fulvestrant
      • Fluoxymesterone
  • Targeted Therapy Drugs
    • Monoclonal Antibodies (mAbs)
      • Bevacizumab
      • Trastuzumab
      • Other mAbs
    • Tyrosine kinase inhibitors
  • Other Therapeutic Drugs

Global Breast Cancer Drugs Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Photopheresis Products Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025

Jul-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4435 | Report Format:

The report covers forecast and analysis for the photopheresis products market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for photopheresis produ...Read More

Implantable Cardioverter Defibrillator Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025

Jul-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4425 | Report Format:

The report covers forecast and analysis for the implantable cardioverter defibrillator market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the...Read More

Insulin Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025

Jul-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4424 | Report Format:

The report covers forecast and analysis for the insulin market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the insulin market along with the ...Read More

Urinalysis Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025

Jul-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4398 | Report Format:

The report covers forecast and analysis for the urinalysis market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the urinalysis market along wit...Read More

Optical Coherence Tomography Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025

Jul-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4397 | Report Format:

The report covers forecast and analysis for the optical coherence tomography market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD million). The study includes drivers and restraints for the optical c...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.